Cargando…

Expression of cutaneous immunity markers during infant skin maturation

BACKGROUND/OBJECTIVES: Infant skin undergoes a maturation process during the early years of life. Little is known about the skin's innate immunity. We investigated the dynamics of innate immunity markers collected from the surface of infant skin during the first 36 months of life. METHODS: A to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirchner, Frank, Capone, Kimberly A., Mack, M. Catherine, Stamatas, Georgios N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055698/
https://www.ncbi.nlm.nih.gov/pubmed/29691908
http://dx.doi.org/10.1111/pde.13516
_version_ 1783341227291181056
author Kirchner, Frank
Capone, Kimberly A.
Mack, M. Catherine
Stamatas, Georgios N.
author_facet Kirchner, Frank
Capone, Kimberly A.
Mack, M. Catherine
Stamatas, Georgios N.
author_sort Kirchner, Frank
collection PubMed
description BACKGROUND/OBJECTIVES: Infant skin undergoes a maturation process during the early years of life. Little is known about the skin's innate immunity. We investigated the dynamics of innate immunity markers collected from the surface of infant skin during the first 36 months of life. METHODS: A total of 117 healthy infants aged 3‐36 months participated in the study. We extracted human beta defensin‐1 and interleukin 1 alpha and its receptor antagonist using transdermal analysis patches from the skin surface of the posterior lower leg area. The extracts were analyzed using a spot enzyme‐linked immunosorbent assay. RESULTS: Skin surface human beta defensin‐1 levels were higher early in life and decreased with infant age. The ratio of interleukin 1 alpha receptor antagonist to interleukin 1 alpha did not change significantly with age but showed a distinct difference between sexes, with female infants having higher values than male infants. CONCLUSION: As is the case with skin structure and functional properties, cutaneous innate immunity also appears to undergo a maturation period during infancy, with innate immunity slowly declining as adaptive immunity takes over. Sex differences in immune markers may explain sex‐dependent susceptibilities to infection.
format Online
Article
Text
id pubmed-6055698
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60556982018-07-23 Expression of cutaneous immunity markers during infant skin maturation Kirchner, Frank Capone, Kimberly A. Mack, M. Catherine Stamatas, Georgios N. Pediatr Dermatol Original Articles BACKGROUND/OBJECTIVES: Infant skin undergoes a maturation process during the early years of life. Little is known about the skin's innate immunity. We investigated the dynamics of innate immunity markers collected from the surface of infant skin during the first 36 months of life. METHODS: A total of 117 healthy infants aged 3‐36 months participated in the study. We extracted human beta defensin‐1 and interleukin 1 alpha and its receptor antagonist using transdermal analysis patches from the skin surface of the posterior lower leg area. The extracts were analyzed using a spot enzyme‐linked immunosorbent assay. RESULTS: Skin surface human beta defensin‐1 levels were higher early in life and decreased with infant age. The ratio of interleukin 1 alpha receptor antagonist to interleukin 1 alpha did not change significantly with age but showed a distinct difference between sexes, with female infants having higher values than male infants. CONCLUSION: As is the case with skin structure and functional properties, cutaneous innate immunity also appears to undergo a maturation period during infancy, with innate immunity slowly declining as adaptive immunity takes over. Sex differences in immune markers may explain sex‐dependent susceptibilities to infection. John Wiley and Sons Inc. 2018-04-25 2018 /pmc/articles/PMC6055698/ /pubmed/29691908 http://dx.doi.org/10.1111/pde.13516 Text en © 2018 Johnson & Johnson Consumer Inc. Pediatric Dermatology published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Kirchner, Frank
Capone, Kimberly A.
Mack, M. Catherine
Stamatas, Georgios N.
Expression of cutaneous immunity markers during infant skin maturation
title Expression of cutaneous immunity markers during infant skin maturation
title_full Expression of cutaneous immunity markers during infant skin maturation
title_fullStr Expression of cutaneous immunity markers during infant skin maturation
title_full_unstemmed Expression of cutaneous immunity markers during infant skin maturation
title_short Expression of cutaneous immunity markers during infant skin maturation
title_sort expression of cutaneous immunity markers during infant skin maturation
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055698/
https://www.ncbi.nlm.nih.gov/pubmed/29691908
http://dx.doi.org/10.1111/pde.13516
work_keys_str_mv AT kirchnerfrank expressionofcutaneousimmunitymarkersduringinfantskinmaturation
AT caponekimberlya expressionofcutaneousimmunitymarkersduringinfantskinmaturation
AT mackmcatherine expressionofcutaneousimmunitymarkersduringinfantskinmaturation
AT stamatasgeorgiosn expressionofcutaneousimmunitymarkersduringinfantskinmaturation